BioNexus Gene Lab Corp Annual Operating Income (Loss) in USD from 2018 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioNexus Gene Lab Corp quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • BioNexus Gene Lab Corp Operating Income (Loss) for the quarter ending December 31, 2024 was -$416K, a 261% decline year-over-year.
  • BioNexus Gene Lab Corp Operating Income (Loss) for the twelve months ending December 31, 2024 was -$1.57M, a 39.3% increase year-over-year.
  • BioNexus Gene Lab Corp annual Operating Income (Loss) for 2024 was -$1.57M, a 39.3% increase from 2023.
  • BioNexus Gene Lab Corp annual Operating Income (Loss) for 2023 was -$2.59M, a 791% decline from 2022.
  • BioNexus Gene Lab Corp annual Operating Income (Loss) for 2022 was -$291K, a 128% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.57M +$1.02M +39.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 -$2.59M -$2.3M -791% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 -$291K -$1.35M -128% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $1.06M -$218K -17.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $1.27M +$1.55M Jan 1, 2020 Dec 31, 2020 10-K 2022-04-06
2019 -$276K -$336K -560% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $59.9K Jan 1, 2018 Dec 31, 2018 10-K 2020-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.